Adma Biologics Net Tangible Assets

Adma Biologics (ADMA) currently reports a net tangible assets of $390M as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Adma Biologics's net tangible assets history and peer comparisons.

Adma Biologics's net tangible assets changed from $0 to $390M (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Adma Biologics reported $390M in net tangible assets as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $390M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Adma Biologics, and consider following ADMA for alerts when major investors trade the stock.

Adma Biologics is classified in the Healthcare sector. On net tangible assets, it currently shows $390M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ADMA with unrelated industries.